A design for the control of apoptosis in genetically modified Saccharomyces cerevisiae

Biosci Biotechnol Biochem. 2014;78(2):358-62. doi: 10.1080/09168451.2014.878224. Epub 2014 Apr 16.

Abstract

We have engineered a system that holds potential for use as a safety switch in genetically modified yeasts. Human apoptotic factor BAX (no homolog in yeast), under the control of the FBP1 (gluconeogenesis enzyme) promoter, was conditionally expressed to induce yeast cell apoptosis after glucose depletion. Such systems might prove useful for the safe use of genetically modified organisms.

Keywords: Bax; Saccharomyces cerevisiae; apoptosis; genetically modified organism (GMO); gluconeogenesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / genetics*
  • Fructose-Bisphosphatase / genetics
  • Genetic Engineering*
  • Humans
  • Promoter Regions, Genetic / genetics
  • Saccharomyces cerevisiae / cytology*
  • Saccharomyces cerevisiae / genetics*
  • Saccharomyces cerevisiae Proteins / genetics
  • bcl-2-Associated X Protein / genetics

Substances

  • Saccharomyces cerevisiae Proteins
  • bcl-2-Associated X Protein
  • FBP1 protein, S cerevisiae
  • Fructose-Bisphosphatase